... Does the Effect of Aspirin Vary by a Priori Subgroups: Age, Sex, Race/Ethnicity, Baseline Cancer Risk, ... Does the Effect of Aspirin Vary by a Priori Subgroups (Age, Sex, Race/Ethnicity, Baseline Cancer Risk, ...

... individuals. Prenatal Testing and Preimplantation Genetic Testing A Priori High-Risk Pregnancies Molecular genetic testing. Once the ... risk and preimplantation genetic testing are possible. A Priori Low-Risk Pregnancies Routine prenatal ultrasound examination may ...

... judgment, rather than based on statistical inference). A Priori Determinations Required in the EPC Approach for Grading ... approach. We recommend that EPC authors identify a priori (in protocols) the major outcomes that they intend ...

... the management. 27 Ways To Determine MID A Priori Versus Post-Protocol Specified MID Having a prespecified ... all clinical areas. Ideally, defining the MID a priori (during protocol development) and providing clinical and statistical ...

... in the regression analyses. Multiple Comparisons and A Priori Hypotheses Meta-regression analysis amounts to studying the ... to which significant findings relate to an a priori hypothesis. In the case of this review, the ...

... individuals. Prenatal Testing and Preimplantation Genetic Diagnosis A priori increased risk for Cantú syndrome and related disorders. ... results of prenatal molecular genetic testing . No a priori increased risk for Cantú syndrome . Since Cantú syndrome ...

... individuals. Prenatal Testing and Preimplantation Genetic Testing A priori high-risk pregnancies. Prenatal testing for pregnancies at ... normal menstrual period or by ultrasound measurements. A priori low-risk pregnancies. Routine prenatal ultrasound examination may ...

... individuals. Prenatal Testing and Preimplantation Genetic Diagnosis A priori high risk. Once an expanded DMPK allele has ... and polyhydramnios, possible indicators of congenital DM1. A priori low risk. For fetuses not known to be ...

... Prenatal Testing and Preimplantation Genetic Diagnosis High a priori risk. Once the PMM2 pathogenic variants have been ... PMM2-CDG ( CDG-Ia ) are possible. Low a priori risk. PMM2-CDG ( CDG-Ia ) molecular testing should ...

... and the relevant stakeholders. There is no a priori preferred modeling perspective. The modeling perspective determines the ...